Please contact Daisy.Flamez@UGent.be for more information:
Technology offer 1: Neuroblastoma (licensing opportunity) Q-PCR test
A neuroblastoma prognostic classifier for improved prediction and patient stratification
Technology_opportunity_Neuroblastoma_prognostic classifier FFMI v3
Prognostic test for Neuroblastoma
Experts: prof Jo Vandesompele, prof Frank Speleman
Technology offer 2: Breast cancer (licensing opportunity) IHC test
prognostic test for ER+ breast cancer GTPase Rab27B biomarker
Experts: prof Olivier De Wever and dr. An Hendrix
Technology offer 3: Colorectal cancer (licensing opportunity) IHC test
Identify patients at risk of developing resistance to HER1 inhibitors: NRG1 biomarker for colorectal cancer TO Neuregulin
Experts: prof Olivier De Wever
Technology offer 4: Targeted resequencing (licensing opportunity) Database
Database targeted resequencing assays for the full human exome
Ghent University Exome targeted reseq assays database
Experts: prof Jo Vandesompele and dr Steve Lefever
Tools and test models: Cancer invasion assays (services) http://www.ecnurad.ugent.be/LECR/en/expertise.html
Cell invasion assay: collagen type I, Chorio-allantoid membrane (CAM) assay, Mice xenograft assay
Partnerships:
Whole genome methylome sequencing, bisulfite sequencing, bioinformatic analysis, transcriptomics
research collaborations with partners of NXTGNT
Experts: prof Wim Van Criekinge, prof Dieter Deforce/